Published in J Womens Health (Larchmt) on March 01, 2010
Explaining ethnic differences in late antenatal care entry by predisposing, enabling and need factors in The Netherlands. The Generation R Study. Matern Child Health J (2011) 0.96
Racial disparities in economic and clinical outcomes of pregnancy among Medicaid recipients. Matern Child Health J (2013) 0.87
The Pittsburgh STOP program: disseminating an evidence-informed intervention for low-income pregnant smokers. Am J Health Promot (2011) 0.81
Medicaid and preterm births in Virginia: an analysis of recent outcomes. J Womens Health (Larchmt) (2010) 0.79
Models of antenatal care to reduce and prevent preterm birth: a systematic review and meta-analysis. BMJ Open (2016) 0.77
Evaluating the effect of hospital and insurance type on the risk of 1-year mortality of very low birth weight infants: controlling for selection bias. Med Care (2012) 0.77
Risk Prediction for Adverse Pregnancy Outcomes in a Medicaid Population. J Womens Health (Larchmt) (2015) 0.77
Role of perceived stress in the occurrence of preterm labor and preterm birth among urban women. J Midwifery Womens Health (2014) 0.75
A randomized trial of psychosocial support during high-risk pregnancies. The Latin American Network for Perinatal and Reproductive Research. N Engl J Med (1992) 3.81
An evaluation of the impact of maternity care coordination on Medicaid birth outcomes in North Carolina. Am J Public Health (1991) 2.58
Infant mortality statistics from the 2004 period linked birth/infant death data set. Natl Vital Stat Rep (2007) 2.36
Medicaid prenatal care: a comparison of use and outcomes in fee-for-service and managed care. Am J Public Health (1992) 2.10
Evaluation of the Medicaid competition demonstrations. Health Care Financ Rev (1989) 1.98
A comparison of capitated and fee-for-service Medicaid reimbursement methods on pregnancy outcomes. Health Serv Res (1998) 1.86
There's something about Medicaid. Health Aff (Millwood) (2003) 1.82
Prenatal WIC participation can reduce low birth weight and newborn medical costs: a cost-benefit analysis of WIC participation in North Carolina. J Am Diet Assoc (1993) 1.77
Primary care case management and birth outcomes in the Iowa Medicaid program. Am J Public Health (1997) 1.65
Impact of augmented prenatal care on birth outcomes of Medicaid recipients in New York City. J Health Econ (1999) 1.44
A randomized trial of augmented prenatal care for multiple-risk, Medicaid-eligible African American women. Am J Public Health (2001) 1.42
A comparison of low birth weight among Medicaid patients of public health departments and other providers of prenatal care in North Carolina and Kentucky. Public Health Rep (1992) 1.38
Support during pregnancy for women at increased risk of low birthweight babies. Cochrane Database Syst Rev (2003) 1.37
Prepaid versus traditional Medicaid plans: lack of effect on pregnancy outcomes and prenatal care. Health Serv Res (1991) 1.34
Randomized trial of comprehensive prenatal care for low-income women: effect on infant birth weight. Pediatrics (1992) 1.29
Impact of a mandatory Medicaid case management program on prenatal care and birth outcomes. A retrospective analysis. Med Care (1991) 1.29
CenteringPregnancy and the current state of prenatal care. J Midwifery Womens Health (2004) 1.26
Health insurance, the quantity and quality of prenatal care, and infant health. Inquiry (1999) 1.24
The effect of expanding Medicaid prenatal services on birth outcomes. Am J Public Health (1998) 1.16
The impact of the Medicaid expansions for pregnant women: a synthesis of the evidence. Med Care Res Rev (2001) 1.13
Reducing low birthweight by resolving risks: results from Colorado's prenatal plus program. Am J Public Health (2005) 1.13
A randomized trial of nurse-midwifery prenatal care to reduce low birth weight. Obstet Gynecol (1990) 1.12
Risk status and pregnancy outcome among medicaid recipients. Am J Prev Med (1989) 1.08
Are outcomes and care processes for preterm neonates influenced by health insurance status? Pediatrics (2009) 1.00
Evaluation of California's statewide implementation of enhanced perinatal services as Medicaid benefits. Public Health Rep (1995) 0.97
Obstetric care and payment source: do low-risk Medicaid women get less care? Am J Public Health (1998) 0.95
Issues and biases in matching medicaid pregnancy episodes to vital records data: the Arkansas experience. Matern Child Health J (2008) 0.94
Medicaid managed care and infant health. J Health Econ (1998) 0.92
The effects of enriched prenatal care services on Medicaid birth outcomes in New Jersey. J Health Econ (1996) 0.92
Transitions in insurance coverage from before pregnancy through delivery in nine states, 1996-1999. Health Aff (Millwood) (2003) 0.91
A comparison of Medicaid and non-Medicaid obstetrical care in California. Health Care Financ Rev (1991) 0.91
The role of public insurance and the public delivery system in improving birth outcomes for low-income pregnant women. Med Care (2002) 0.89
Evaluating the social and economic impact of community-based prenatal care. Public Health Nurs (2007) 0.87
Effects of Tennessee Medicaid managed care on obstetrical care and birth outcomes. J Health Polit Policy Law (2001) 0.87
Timing of enhanced prenatal care and birth outcomes in New Jersey's HealthStart program. Matern Child Health J (2005) 0.86
The effect of the Family Case Management Program on 1996 birth outcomes in Illinois. J Womens Health (Larchmt) (2004) 0.85
Evaluation of the effectiveness of a community-based enriched model prenatal intervention project in the District of Columbia. Health Serv Res (1996) 0.85
Evaluation of a program for prenatal care case management. Fam Plann Perspect (1996) 0.85
The impact of nurse case management home visitation on birth outcomes in African-American women. J Natl Med Assoc (2008) 0.84
Preterm delivery among women in the South Carolina Medicaid High Risk Channeling Project. J Health Care Poor Underserved (1995) 0.83
Selection bias in prenatal care use by Medicaid recipients. Matern Child Health J (2003) 0.83
South Carolina Partners for Preterm Birth Prevention: a regional perinatal initiative for the reduction of premature birth in a Medicaid population. Am J Obstet Gynecol (2008) 0.82
Preventing low birth weight in Illinois: outcomes of the family case management program. Matern Child Health J (2006) 0.81
Explaining variation in birth outcomes of Medicaid-eligible women with variation in the adequacy of prenatal support services. Med Care (1998) 0.81
Perinatal outcomes following implementation of TennCare. JAMA (1998) 0.81
Public finance policy strategies to increase access to preconception care. Matern Child Health J (2006) 0.80
Outcomes of enhanced prenatal services for Medicaid-eligible women in public and private settings. Public Health Rep (1997) 0.79
Effects of psychosocial risk factors and prenatal interventions on birth weight: evidence from New Jersey's HealthStart program. Perspect Sex Reprod Health (2003) 0.79
Implementation of mandatory Medicaid managed care in Missouri: impacts for pregnant women. Am J Manag Care (2005) 0.79
Medicaid maternal and child health care: prepaid plans vs. private fee-for-service. Res Nurs Health (1990) 0.78
Maternity and infant care, race and birth outcomes. J Health Soc Policy (2004) 0.78
A clinical trial to reduce the rate of low birth weight in an inner-city black population. Fam Med (1992) 0.78
An evaluation of a Medicaid managed maternity program: the impact of comprehensive care coordination on utilization and pregnancy outcomes. J Health Hum Serv Adm (2003) 0.76
Comprehensive interdisciplinary care: making a difference in pregnancy outcomes for Hispanic women. Public Health Nurs (1996) 0.76
Derivation of oocytes from mouse embryonic stem cells. Science (2003) 4.03
Inflammation and pregnancy. Reprod Sci (2009) 3.33
A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth. Am J Obstet Gynecol (2004) 2.60
Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature (2008) 2.09
Family-based analysis of candidate genes for polycystic ovary syndrome. J Clin Endocrinol Metab (2010) 1.84
Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertil Steril (2006) 1.75
The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. J Biol Chem (2003) 1.59
Health disparities in risk for cervical insufficiency. Hum Reprod (2010) 1.58
Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J Clin Endocrinol Metab (2006) 1.51
Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J Med Genet (2011) 1.51
A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J Biol Chem (2001) 1.42
NIH funding reform. Science (2005) 1.41
Catechol-O-methyltransferase (COMT) single nucleotide polymorphisms and haplotypes are not major risk factors for polycystic ovary syndrome. Mol Cell Endocrinol (2011) 1.38
Genetic contributions to disparities in preterm birth. Pediatr Res (2009) 1.37
Molecular progress in infertility: polycystic ovary syndrome. Fertil Steril (2002) 1.36
Functionally significant SNP MMP8 promoter haplotypes and preterm premature rupture of membranes (PPROM). Hum Mol Genet (2004) 1.35
Drawing the line between commensal and pathogenic Gardnerella vaginalis through genome analysis and virulence studies. BMC Genomics (2010) 1.34
Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype. Proc Natl Acad Sci U S A (2014) 1.28
A functional SNP in the promoter of the SERPINH1 gene increases risk of preterm premature rupture of membranes in African Americans. Proc Natl Acad Sci U S A (2006) 1.27
Treatment of localized periodontal disease in pregnancy does not reduce the occurrence of preterm birth: results from the Periodontal Infections and Prematurity Study (PIPS). Am J Obstet Gynecol (2010) 1.26
Genomics and perinatal care. N Engl J Med (2012) 1.26
Temporal and spatial changes in transcription factor binding and histone modifications at the steroidogenic acute regulatory protein (stAR) locus associated with stAR transcription. Mol Endocrinol (2004) 1.22
Dissecting the axoneme interactome: the mammalian orthologue of Chlamydomonas PF6 interacts with sperm-associated antigen 6, the mammalian orthologue of Chlamydomonas PF16. Mol Cell Proteomics (2005) 1.21
Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome. Mol Endocrinol (2004) 1.18
A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod (2002) 1.17
Haploinsufficiency for the murine orthologue of Chlamydomonas PF20 disrupts spermatogenesis. Proc Natl Acad Sci U S A (2004) 1.17
FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome. PLoS One (2011) 1.16
Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis. J Clin Endocrinol Metab (2012) 1.14
Deficiency of SPAG16L causes male infertility associated with impaired sperm motility. Biol Reprod (2005) 1.14
Syncytiotrophoblast is a barrier to maternal-fetal transmission of herpes simplex virus. Biol Reprod (2002) 1.14
A sperm-associated WD repeat protein orthologous to Chlamydomonas PF20 associates with Spag6, the mammalian orthologue of Chlamydomonas PF16. Mol Cell Biol (2002) 1.12
The promoter of the oocyte-specific gene, Gdf9, is active in population of cultured mouse embryonic stem cells with an oocyte-like phenotype. Methods (2008) 1.10
MLN64 mediates mobilization of lysosomal cholesterol to steroidogenic mitochondria. J Biol Chem (2002) 1.07
Accelerated mortality from hydrocephalus and pneumonia in mice with a combined deficiency of SPAG6 and SPAG16L reveals a functional interrelationship between the two central apparatus proteins. Cell Motil Cytoskeleton (2007) 1.07
A single nucleotide polymorphism in the promoter of the LOXL1 gene and its relationship to pelvic organ prolapse and preterm premature rupture of membranes. Reprod Sci (2009) 1.06
Mechanisms underlying "functional" progesterone withdrawal at parturition. Ann N Y Acad Sci (2004) 1.04
Patterns of expression of sperm flagellar genes: early expression of genes encoding axonemal proteins during the spermatogenic cycle and shared features of promoters of genes encoding central apparatus proteins. Mol Hum Reprod (2005) 1.04
Epistasis between COMT and MTHFR in maternal-fetal dyads increases risk for preeclampsia. PLoS One (2011) 1.04
Sex hormone-binding globulin and type 2 diabetes mellitus. Trends Endocrinol Metab (2011) 1.02
Genetic and epigenetic mechanisms combine to control MMP1 expression and its association with preterm premature rupture of membranes. Hum Mol Genet (2008) 1.01
Fetal ERAP2 variation is associated with preeclampsia in African Americans in a case-control study. BMC Med Genet (2011) 1.01
Estimating fetal and maternal genetic contributions to premature birth from multiparous pregnancy histories of twins using MCMC and maximum-likelihood approaches. Twin Res Hum Genet (2009) 1.00
Racial differences in genetic and environmental risk to preterm birth. PLoS One (2010) 0.99
Expression profile of male germ cell-associated genes in mouse embryonic stem cell cultures treated with all-trans retinoic acid and testosterone. Mol Reprod Dev (2009) 0.99
Valproate potentiates androgen biosynthesis in human ovarian theca cells. Endocrinology (2003) 0.98
The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling. J Reprod Immunol (2004) 0.98
MEIG1 is essential for spermiogenesis in mice. Proc Natl Acad Sci U S A (2009) 0.98
Targeted mutation of the MLN64 START domain causes only modest alterations in cellular sterol metabolism. J Biol Chem (2004) 0.98
Variation in resistin gene promoter not associated with polycystic ovary syndrome. Diabetes (2003) 0.97
Genetics of polycystic ovarian syndrome. Clin Obstet Gynecol (2007) 0.96
Targeted deletion of Tssk1 and 2 causes male infertility due to haploinsufficiency. Dev Biol (2008) 0.96
Viral infection of the trophoblast: time to take a serious look at its role in abnormal implantation and placentation? J Reprod Immunol (2002) 0.96
Retinoids and retinol differentially regulate steroid biosynthesis in ovarian theca cells isolated from normal cycling women and women with polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 0.95
Induction of the hyaluronic acid-binding protein, tumor necrosis factor-stimulated gene-6, in cervical smooth muscle cells by tumor necrosis factor-alpha and prostaglandin E(2). Am J Pathol (2002) 0.95
Control of human luteal steroidogenesis. Mol Cell Endocrinol (2002) 0.94
Tumor necrosis factor-alpha suppresses the expression of steroid receptor coactivator-1 and -2: a possible mechanism contributing to changes in steroid hormone responsiveness. FASEB J (2004) 0.93
Steroid sulfotransferase 2A1 gene transcription is regulated by steroidogenic factor 1 and GATA-6 in the human adrenal. Mol Endocrinol (2004) 0.93
Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects. Physiol Genomics (2004) 0.93
Activation of the control reporter plasmids pRL-TK and pRL-SV40 by multiple GATA transcription factors can lead to aberrant normalization of transfection efficiency. BMC Biotechnol (2004) 0.93
Transcriptional regulation of an axonemal central apparatus gene, sperm-associated antigen 6, by a SRY-related high mobility group transcription factor, S-SOX5. J Biol Chem (2010) 0.92
A heterozygous mutation disrupting the SPAG16 gene results in biochemical instability of central apparatus components of the human sperm axoneme. Biol Reprod (2007) 0.91
Fetal and maternal genes' influence on gestational age in a quantitative genetic analysis of 244,000 Swedish births. Am J Epidemiol (2013) 0.91
An exploratory study of an assessment tool derived from the competencies of the interprofessional education collaborative. J Interprof Care (2014) 0.90
Regulation of transcription of the steroidogenic acute regulatory protein (StAR) gene: temporal and spatial changes in transcription factor binding and histone modification. Mol Cell Endocrinol (2004) 0.90
Lessons for coverage expansion: a Virginia primary care program for the uninsured reduced utilization and cut costs. Health Aff (Millwood) (2012) 0.89
Spag16, an axonemal central apparatus gene, encodes a male germ cell nuclear speckle protein that regulates SPAG16 mRNA expression. PLoS One (2011) 0.89
Genetic approaches to polycystic ovarian syndrome. Curr Opin Obstet Gynecol (2007) 0.89
The CARD15 2936insC mutation and TLR4 896 A>G polymorphism in African Americans and risk of preterm premature rupture of membranes (PPROM). Mol Hum Reprod (2002) 0.88
Persistence pays off for PCOS gene prospectors. J Clin Endocrinol Metab (2012) 0.87
DNA methylation is altered in maternal blood vessels of women with preeclampsia. Reprod Sci (2012) 0.87
Transport of plasma membrane-derived cholesterol and the function of Niemann-Pick C1 Protein. FASEB J (2003) 0.87
Increased transcription and increased messenger ribonucleic acid (mRNA) stability contribute to increased GATA6 mRNA abundance in polycystic ovary syndrome theca cells. J Clin Endocrinol Metab (2005) 0.86
Increased expression of matrix metalloproteinase-1 in systemic vessels of preeclamptic women: a critical mediator of vascular dysfunction. Am J Pathol (2010) 0.86
Stromal cells of the human postmenopausal ovary display a distinctive biochemical and molecular phenotype. J Clin Endocrinol Metab (2003) 0.86
Reduced methylation of the thromboxane synthase gene is correlated with its increased vascular expression in preeclampsia. Hypertension (2012) 0.86
Is laminin gamma-1 a candidate gene for advanced pelvic organ prolapse? Am J Obstet Gynecol (2010) 0.86
Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome. Fertil Steril (2011) 0.86
Sperm-associated antigen-17 gene is essential for motile cilia function and neonatal survival. Am J Respir Cell Mol Biol (2013) 0.85
Multiple signal transduction pathways regulate ovarian steroidogenesis. Rev Endocr Metab Disord (2002) 0.85
Contact sites from human placental mitochondria: characterization and role in progesterone synthesis. Arch Biochem Biophys (2003) 0.85
Strategies to facilitate the development of new contraceptives. Nat Rev Drug Discov (2004) 0.84
Phosphorylation of mouse sperm axoneme central apparatus protein SPAG16L by a testis-specific kinase, TSSK2. Biol Reprod (2008) 0.84
Human corpus luteum physiology and the luteal-phase dysfunction associated with ovarian stimulation. Reprod Biomed Online (2009) 0.84
Growth differentiation factor-9 inhibits 3'5'-adenosine monophosphate-stimulated steroidogenesis in human granulosa and theca cells. J Clin Endocrinol Metab (2002) 0.83
Phased implementation of electronic health records through an office of clinical transformation. J Am Med Inform Assoc (2011) 0.83
Thrombin receptors and protease-activated receptor-2 in human placentation: receptor activation mediates extravillous trophoblast invasion in vitro. Am J Pathol (2003) 0.83
Cholesterol side-chain cleavage gene expression in theca cells: augmented transcriptional regulation and mRNA stability in polycystic ovary syndrome. PLoS One (2012) 0.83
PDE8A genetic variation, polycystic ovary syndrome and androgen levels in women. Mol Hum Reprod (2009) 0.83
Medicare and Medicaid managed care: a tale of two trajectories. Am J Manag Care (2006) 0.83
A 12-bp deletion in the 5'-flanking region of the SERPINH1 gene affects promoter activity and protects against preterm premature rupture of membranes in African Americans. Hum Mutat (2008) 0.82
TSKS concentrates in spermatid centrioles during flagellogenesis. Dev Biol (2008) 0.82
A Novel ERAP2 Haplotype Structure in a Chilean Population: Implications for ERAP2 Protein Expression and Preeclampsia Risk. Mol Genet Genomic Med (2013) 0.82
Preeclampsia is associated with alterations in DNA methylation of genes involved in collagen metabolism. Am J Pathol (2012) 0.82
Polymorphisms in the SHBG gene influence serum SHBG levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2011) 0.82
Endocrine function of the postmenopausal ovary. Endocrinol Metab Clin North Am (2004) 0.81
The human corpus luteum: life cycle and function in natural cycles. Fertil Steril (2008) 0.81
Transient expression of progesterone receptor and cathepsin-l in human granulosa cells during the periovulatory period. Fertil Steril (2012) 0.81
The steroidogenic response and corpus luteum expression of the steroidogenic acute regulatory protein after human chorionic gonadotropin administration at different times in the human luteal phase. J Clin Endocrinol Metab (2003) 0.81
Cholesterol interaction with the related steroidogenic acute regulatory lipid-transfer (START) domains of StAR (STARD1) and MLN64 (STARD3). FEBS J (2008) 0.81